Transcriptomics

Dataset Information

0

RNA-seq of Multilineage differentiating stress-enduring enriched cells (MECs) derived from MenSCs


ABSTRACT: The increasing interest in multilineage differentiating stress-enduring (Muse) cells within the field of regenerative medicine is attributed to their exceptional homing capabilities, prolonged viability in adverse conditions, and enhanced three-germ-layer differentiate ability, surpassing their parent mesenchymal stem cells. Given their abundant sources, non-invasive collection procedure, and periodic availability, human menstrual blood-derived endometrium stem cells (MenSCs) have been extensively investigated as a potential resource for stem cell-based therapies. However, there is no established modality to isolate Muse cells from MenSCs and disparity in gene expression profiles between Muse cells and MenSCs remain unknown. In this study, Muse cells were isolated from MenSCs by long-time trypsin incubation method. Muse cells expressed pluripotency markers and could realize trilineage differentiation in vitro. Compared with MenSCs, Muse cells showed enhanced homing ability and superior therapeutic efficacy in animal models of acute liver injury (ALI) and intracerebral hemorrhage (ICH). Furthermore, the RNA-seq analysis offers insights into the mechanism underlying the disparity in trypsin resistance and migration ability between Muse and MenSCs cells. This research offers a significant foundation for further exploration of cell-based therapies using MenSCs-derived Muse cells in the context of various human diseases, highlighting their promising application in the field of regenerative medicine.

ORGANISM(S): Homo sapiens

PROVIDER: GSE247588 | GEO | 2024/01/01

REPOSITORIES: GEO

Similar Datasets

2024-04-18 | GSE263992 | GEO
2023-03-11 | PXD037033 | Pride
2023-07-17 | PXD036883 | Pride
2022-10-26 | E-MTAB-10854 | biostudies-arrayexpress
2013-04-24 | GSE46353 | GEO
2013-04-24 | E-GEOD-46353 | biostudies-arrayexpress
2014-05-24 | GSE48797 | GEO
2022-10-12 | PXD036148 | Pride
| PRJNA691618 | ENA
2023-04-03 | GSE228520 | GEO